Uçakhan O O, Brodie S E, Desnick R, Willner J, Asbell P A
Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
CLAO J. 2001 Oct;27(4):234-7.
To present a case of Maroteaux-Lamy syndrome (MLS, mucopolysaccharidosis [MPS] type VI) who underwent bone marrow transplantation (BMT) for gene transfer at the age of 13, and penetrating keratoplasty at the age of 17, and maintained clear corneal grafts bilaterally for 13 years. To our knowledge, this is the longest follow-up reported on corneal graft survival in a patient with MLS and BMT.
In 1982, BMT was successfully performed on a 13-year-old girl with MLS with growth retardation, typical facial features, skeletal and joint deformities, hepatosplenomegaly, cardiopulmonary dysfunction, and corneal clouding. Corneal transplantation was done on the left eye in 1986, and on the right eye in 1987 (6 months later) without difficulty or complication.
Thirteen years postoperatively, the patient was systemically well, and both eyes retained clear corneal grafts.
BMT retarded further dysfunction from MLS, and the corneal transplants retained clarity. Further controlled studies with longer follow-up are required to establish the efficacy of BMT in ocular manifestations of MPS or MLS.
报告一例13岁时接受骨髓移植(BMT)进行基因转移、17岁时接受穿透性角膜移植术,并双侧角膜移植片保持透明13年的马罗-拉米综合征(MLS,黏多糖贮积症[MPS] VI型)患者。据我们所知,这是关于MLS和BMT患者角膜移植存活时间最长的随访报道。
1982年,对一名患有MLS的13岁女孩成功进行了BMT,该女孩有生长发育迟缓、典型面部特征、骨骼和关节畸形、肝脾肿大、心肺功能障碍以及角膜混浊。1986年对左眼进行了角膜移植,1987年(6个月后)对右眼进行角膜移植,手术顺利,无并发症。
术后13年,患者全身状况良好,双眼角膜移植片均保持透明。
BMT延缓了MLS的进一步功能障碍,角膜移植片保持透明。需要进行更长时间随访的进一步对照研究,以确定BMT在MPS或MLS眼部表现中的疗效。